Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Somatostatin Receptor Type 2 Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Somatostatin Receptor Type 2 Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 CRN-00808
      • 1.3.3 Lanreotide Acetate
      • 1.3.4 PRL-2903
      • 1.3.5 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Somatostatin Receptor Type 2 Market Share by Application (2019-2025)
      • 1.4.2 Hormonal Disorder
      • 1.4.3 Oncology
      • 1.4.4 Metabolic Disorder
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Somatostatin Receptor Type 2 Market Size
      • 2.1.1 Global Somatostatin Receptor Type 2 Revenue 2014-2025
      • 2.1.2 Global Somatostatin Receptor Type 2 Sales 2014-2025
    • 2.2 Somatostatin Receptor Type 2 Growth Rate by Regions
      • 2.2.1 Global Somatostatin Receptor Type 2 Sales by Regions 2014-2019
      • 2.2.2 Global Somatostatin Receptor Type 2 Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Somatostatin Receptor Type 2 Sales by Manufacturers
      • 3.1.1 Somatostatin Receptor Type 2 Sales by Manufacturers 2014-2019
      • 3.1.2 Somatostatin Receptor Type 2 Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Somatostatin Receptor Type 2 Revenue by Manufacturers (2014-2019)
      • 3.2.2 Somatostatin Receptor Type 2 Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Somatostatin Receptor Type 2 Market Concentration Ratio (CR5 and HHI)
    • 3.3 Somatostatin Receptor Type 2 Price by Manufacturers
    • 3.4 Key Manufacturers Somatostatin Receptor Type 2 Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Somatostatin Receptor Type 2 Market
    • 3.6 Key Manufacturers Somatostatin Receptor Type 2 Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 CRN-00808 Sales and Revenue (2014-2019)
      • 4.1.2 Lanreotide Acetate Sales and Revenue (2014-2019)
      • 4.1.3 PRL-2903 Sales and Revenue (2014-2019)
      • 4.1.4 Others Sales and Revenue (2014-2019)
    • 4.2 Global Somatostatin Receptor Type 2 Sales Market Share by Type
    • 4.3 Global Somatostatin Receptor Type 2 Revenue Market Share by Type
    • 4.4 Somatostatin Receptor Type 2 Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Somatostatin Receptor Type 2 Sales by Application

    6 United States

    • 6.1 United States Somatostatin Receptor Type 2 Breakdown Data by Company
    • 6.2 United States Somatostatin Receptor Type 2 Breakdown Data by Type
    • 6.3 United States Somatostatin Receptor Type 2 Breakdown Data by Application

    7 European Union

    • 7.1 European Union Somatostatin Receptor Type 2 Breakdown Data by Company
    • 7.2 European Union Somatostatin Receptor Type 2 Breakdown Data by Type
    • 7.3 European Union Somatostatin Receptor Type 2 Breakdown Data by Application

    8 China

    • 8.1 China Somatostatin Receptor Type 2 Breakdown Data by Company
    • 8.2 China Somatostatin Receptor Type 2 Breakdown Data by Type
    • 8.3 China Somatostatin Receptor Type 2 Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Somatostatin Receptor Type 2 Breakdown Data by Company
    • 9.2 Rest of World Somatostatin Receptor Type 2 Breakdown Data by Type
    • 9.3 Rest of World Somatostatin Receptor Type 2 Breakdown Data by Application
    • 9.4 Rest of World Somatostatin Receptor Type 2 Breakdown Data by Countries
      • 9.4.1 Rest of World Somatostatin Receptor Type 2 Sales by Countries
      • 9.4.2 Rest of World Somatostatin Receptor Type 2 Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Amryt Pharma plc
      • 10.1.1 Amryt Pharma plc Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Somatostatin Receptor Type 2
      • 10.1.4 Somatostatin Receptor Type 2 Product Introduction
      • 10.1.5 Amryt Pharma plc Recent Development
    • 10.2 Crinetics Pharmaceuticals Inc
      • 10.2.1 Crinetics Pharmaceuticals Inc Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Somatostatin Receptor Type 2
      • 10.2.4 Somatostatin Receptor Type 2 Product Introduction
      • 10.2.5 Crinetics Pharmaceuticals Inc Recent Development
    • 10.3 Daewoong Pharmaceutical Co Ltd
      • 10.3.1 Daewoong Pharmaceutical Co Ltd Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Somatostatin Receptor Type 2
      • 10.3.4 Somatostatin Receptor Type 2 Product Introduction
      • 10.3.5 Daewoong Pharmaceutical Co Ltd Recent Development
    • 10.4 Ipsen SA
      • 10.4.1 Ipsen SA Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Somatostatin Receptor Type 2
      • 10.4.4 Somatostatin Receptor Type 2 Product Introduction
      • 10.4.5 Ipsen SA Recent Development
    • 10.5 Progenics Pharmaceuticals Inc
      • 10.5.1 Progenics Pharmaceuticals Inc Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Somatostatin Receptor Type 2
      • 10.5.4 Somatostatin Receptor Type 2 Product Introduction
      • 10.5.5 Progenics Pharmaceuticals Inc Recent Development
    • 10.6 Strongbridge Biopharma plc
      • 10.6.1 Strongbridge Biopharma plc Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Somatostatin Receptor Type 2
      • 10.6.4 Somatostatin Receptor Type 2 Product Introduction
      • 10.6.5 Strongbridge Biopharma plc Recent Development
    • 10.7 Zucara Therapeutics Inc
      • 10.7.1 Zucara Therapeutics Inc Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Somatostatin Receptor Type 2
      • 10.7.4 Somatostatin Receptor Type 2 Product Introduction
      • 10.7.5 Zucara Therapeutics Inc Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Somatostatin Receptor Type 2 Sales Channels
      • 11.2.2 Somatostatin Receptor Type 2 Distributors
    • 11.3 Somatostatin Receptor Type 2 Customers

    12 Market Forecast

    • 12.1 Global Somatostatin Receptor Type 2 Sales and Revenue Forecast 2019-2025
    • 12.2 Global Somatostatin Receptor Type 2 Sales Forecast by Type
    • 12.3 Global Somatostatin Receptor Type 2 Sales Forecast by Application
    • 12.4 Somatostatin Receptor Type 2 Forecast by Regions
      • 12.4.1 Global Somatostatin Receptor Type 2 Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Somatostatin Receptor Type 2 Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Somatostatin Receptor Type 2 is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Somatostatin Receptor Type 2.

      This report studies the global market size of Somatostatin Receptor Type 2, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Somatostatin Receptor Type 2 sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Amryt Pharma plc
      Crinetics Pharmaceuticals Inc
      Daewoong Pharmaceutical Co Ltd
      Ipsen SA
      Progenics Pharmaceuticals Inc
      Strongbridge Biopharma plc
      Zucara Therapeutics Inc
      ...

      Market Segment by Product Type
      CRN-00808
      Lanreotide Acetate
      PRL-2903
      Others

      Market Segment by Application
      Hormonal Disorder
      Oncology
      Metabolic Disorder
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Somatostatin Receptor Type 2 status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Somatostatin Receptor Type 2 manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Somatostatin Receptor Type 2 are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now